Brief: Viva Biotech Holdings Says In Discussions With Zhejiang Langhua Pharmaceutical
27/12/2019 13:06
Dec 27 (Reuters) - VIVA Biotech Holdings 1873.HK :
* IN DISCUSSIONS WITH ZHEJIANG LANGHUA PHARMACEUTICAL IN
CONNECTION WITH POTENTIAL STRATEGIC INVESTMENT & COOPERATION
* GROUP HAS NOT ENTERED INTO ANY DEFINITIVE AGREEMENT IN
RELATION
TO POTENTIAL STRATEGIC INVESTMENT AND COOPERATION
Source text for Eikon: urn:newsml:reuters.com:*:nHKSXGMC6
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical